# Recovery from apoptosis in photoreceptor cells: A role for mitophagy

**Authors:** Bhavneet Kaur, Bruna Miglioranza Scavuzzi, Jingyu Yao, Mengling Yang, Lin Jia, Stephen I. Lentz, Jaya Sadda, Andrew J. Kocab, Sumathi Shanmugam, David N. Zacks

PMC · DOI: 10.1038/s41419-026-08436-3 · Cell Death & Disease · 2026-01-30

## TL;DR

This study shows that photoreceptor cells can recover from apoptosis, with mitophagy playing a key role in their survival.

## Contribution

The first demonstration that photoreceptor cells can recover from apoptosis and that mitophagy is essential for this recovery.

## Key findings

- Photoreceptor cells can recover from apoptosis after stressors like staurosporine or hypoxia.
- Mitophagy is crucial for recovery, as shown by increased mitophagy markers and protection with MF-094.
- Mitochondrial function restoration is central to photoreceptor recovery from apoptosis.

## Abstract

Photoreceptors (PRs) are specialized light-sensitive cells responsible for vision, and their death is the primary cause of retinal degeneration and vision loss. Recent studies using cells such as HeLa and PC12 have demonstrated cellular recovery even from late stages of apoptosis. Here, we demonstrate for the first time that PR cells can recover from features of apoptosis following exposure to apoptotic stressors. Upon apoptotic stimuli (staurosporine or hypoxia), 661 W cells, a murine cone PR cell line, exhibited morphological and functional features of apoptosis, such as rounding and blebbing, caspase-3 activation, PARP cleavage, and phosphatidylserine externalization. These processes were reversed upon the alleviation of stress. We also observed that mitochondrial function is central to apoptotic recovery of photoreceptor cells, as evidenced by the restoration of intracellular ATP levels and reduction in mitochondrial reactive oxygen species (mROS). Mitophagy was demonstrated to play a crucial role in cell survival, with increased protein and mRNA expression of mitophagy markers during recovery from apoptosis. Furthermore, the modulation of mitophagy confirmed its protective role in the recovery phase, as its induction with MF-094 reduced apoptosis while its inhibition with Mdivi-1 exacerbated cell death. In vivo, we demonstrate the recovery of PRs from apoptosis using an experimental model of transient retinal detachment. Altogether, the findings of this study indicate that PR cells can recover from entry into the apoptotic cascade, and that mitophagy is essential for apoptotic recovery in these cells.

## Linked entities

- **Proteins:** Casp3 (caspase 3), PARP1 (poly(ADP-ribose) polymerase 1)
- **Chemicals:** staurosporine (PubChem CID 5279), MF-094 (PubChem CID 138319686), Mdivi-1 (PubChem CID 3825829)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Anxa5 (annexin A5) [NCBI Gene 11747] {aka Anx5, CPB-I}, Ndufv1 (NADH:ubiquinone oxidoreductase core subunit V1) [NCBI Gene 17995] {aka CI-51kD}, SNAI1 (snail family transcriptional repressor 1) [NCBI Gene 6615] {aka SLUGH2, SNA, SNAH, SNAIL, SNAIL1, dJ710H13.1}, Dnm1l (dynamin 1-like) [NCBI Gene 74006] {aka 6330417M19Rik, Dlp1, Dnmlp1, Drp1, python}, Parp1 (poly (ADP-ribose) polymerase family, member 1) [NCBI Gene 11545] {aka 5830444G22Rik, ARTD1, Adprp, Adprt1, PARP, PPOL}, JUN (Jun proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 3725] {aka AP-1, AP1, c-Jun, cJUN, p39}, Opa1 (OPA1, mitochondrial dynamin like GTPase) [NCBI Gene 74143] {aka 1200011N24Rik, lilr3, mKIAA0567}, Capn1 (calpain 1) [NCBI Gene 12333] {aka Capa-1, Capa1, mu-calpin}, Fundc1 (FUN14 domain containing 1) [NCBI Gene 72018] {aka 1500005J14Rik, 1810033P05Rik}, Ppargc1a (peroxisome proliferative activated receptor, gamma, coactivator 1 alpha) [NCBI Gene 19017] {aka A830037N07Rik, Gm11133, PGC-1, PPARGC-1-alpha, Pgc-1alpha, Pgc1}, Map1lc3b (microtubule-associated protein 1 light chain 3 beta) [NCBI Gene 67443] {aka 1010001C15Rik, Atg8, LC3b, MAP1A/MAP1B, Map1lc3}, Phex (phosphate regulating endopeptidase homolog, X-linked) [NCBI Gene 18675] {aka Gy, HPDR, HPDR1, Hyp, PEX}, Sirt1 (sirtuin 1) [NCBI Gene 93759] {aka SIR2L1, Sir2, Sir2a, Sir2alpha}, GADD45A (growth arrest and DNA damage inducible alpha) [NCBI Gene 1647] {aka DDIT1, GADD45}, Casp3 (caspase 3) [NCBI Gene 12367] {aka A830040C14Rik, AC-3, CASP-3, CC3, CPP-32, CPP32}, Atg5 (autophagy related 5) [NCBI Gene 11793] {aka 2010107M05Rik, 3110067M24Rik, Apg5l, Atg5l, Paddy}, PPP1R15A (protein phosphatase 1 regulatory subunit 15A) [NCBI Gene 23645] {aka GADD34}, Dntt (deoxynucleotidyltransferase, terminal) [NCBI Gene 21673] {aka Tdt}, Actb (actin, beta) [NCBI Gene 11461] {aka Actx, E430023M04Rik, beta-actin}, Anxa11os (annexin A11, opposite strand) [NCBI Gene 105245705] {aka Gm9872}, FOS (Fos proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 2353] {aka AP-1, C-FOS, p55}, Casp8 (caspase 8) [NCBI Gene 12370] {aka CASP-8, FLICE, MACH, Mch5}, IER5 (immediate early response 5) [NCBI Gene 51278] {aka SBBI48}, EFNB2 (ephrin B2) [NCBI Gene 1948] {aka EPLG5, HTKL, Htk-L, LERK5, ephrin-B2}, Rho (rhodopsin) [NCBI Gene 212541] {aka Noerg1, Opn2, Ops, RP4}, Mfn1 (mitofusin 1) [NCBI Gene 67414] {aka 2310002F04Rik, 6330416C07Rik, D3Ertd265e, HR2, mKIAA4032}, PTGS2 (prostaglandin-endoperoxide synthase 2) [NCBI Gene 5743] {aka COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2}, Pink1 (PTEN induced putative kinase 1) [NCBI Gene 68943] {aka 1190006F07Rik, BRPK, mFLJ00387}, Hif1a (hypoxia inducible factor 1, alpha subunit) [NCBI Gene 15251] {aka HIF-1-alpha, HIF1-alpha, HIF1alpha, MOP1, bHLHe78}, Usp30 (ubiquitin specific peptidase 30) [NCBI Gene 100756] {aka 6330590F17Rik, D5Ertd483e}, Pum1 (pumilio RNA-binding family member 1) [NCBI Gene 80912] {aka Pumm, mKIAA0099}, EGR1 (early growth response 1) [NCBI Gene 1958] {aka AT225, G0S30, KROX-24, NGFI-A, TIS8, ZIF-268}, Mfn2 (mitofusin 2) [NCBI Gene 170731] {aka D630023P19Rik, Fzo}
- **Diseases:** retinal degeneration (MESH:D012162), vision loss (MESH:D014786), mitochondrial dysfunction (MESH:D028361), RD (MESH:D012163), Musculoskeletal and Skin Diseases (MESH:D009140), AMD (MESH:D008268), neurodegenerative diseases (MESH:D019636), Hypoxia (MESH:D002534), PR degeneration (MESH:D009410), cytotoxicity (MESH:D064420), glaucoma (MESH:D005901), photoreceptor (MESH:D012173), H (MESH:D000848), hypoxia (MESH:D000860), necrotic (MESH:D009336), retinitis pigmentosa (MESH:D012174), Arthritis (MESH:D001168), retinal diseases (MESH:D012164), mitochondrial fragmentation (MESH:D012892)
- **Chemicals:** N2 (MESH:D009584), sphingosine (MESH:D013110), O2 (MESH:D013481), disodium phosphate (MESH:C018279), glycyl-L-phenylalanine 2-naphthylamide (MESH:C041865), methanol (MESH:D000432), DRAQ5 (-), isopropanol (MESH:D019840), formazan (MESH:D005562), dUTP (MESH:C027078), putrescine (MESH:D011700), jasplakinolide (MESH:C057531), EDTA (MESH:D004492), streptomycin (MESH:D013307), PI (MESH:D011419), ethanol (MESH:D000431), STR (MESH:D019311), paraformaldehyde (MESH:C003043), Tween 20 (MESH:D011136), penicillin (MESH:D010406), Mdivi-1 (MESH:C000723896), ROS (MESH:D017382), PS (MESH:D010718), ATP (MESH:D000255), FITC (MESH:D016650), PVDF (MESH:C024865), E (MESH:D004540), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MESH:C022616), -T (MESH:D014316), eosin (MESH:D004801), MitoSOX (MESH:C521281), hematoxylin (MESH:D006416), Crystal violet (MESH:D005840), PBS (MESH:D007854), sodium hyaluronate (MESH:D006820), MTT (MESH:C070243), CO2 (MESH:D002245), Paraffin (MESH:D010232), potassium chloride (MESH:D011189), water (MESH:D014867), sodium chloride (MESH:D012965), MF-094 (MESH:C000721067), SYBR Green (MESH:C098022), progesterone (MESH:D011374)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** 661 — Homo sapiens (Human), Lung large cell carcinoma, Cancer cell line (CVCL_1577), PC12 — Rattus norvegicus (Rat), Rat adrenal gland pheochromocytoma, Cancer cell line (CVCL_0481), HeLa — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_0030), 661 W — Mus musculus (Mouse), Transformed cell line (CVCL_6240)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12877012/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12877012/full.md

## References

34 references — full list in the complete paper: https://tomesphere.com/paper/PMC12877012/full.md

---
Source: https://tomesphere.com/paper/PMC12877012